NCT07106021View on ClinicalTrials.gov

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

June 30, 2031

Conditions
Idiopathic Parkinson´s DiseaseParkinson's Disease
Interventions
BIOLOGICAL

RNDP-001

Stem cells

DEVICE

Syringe Front-Loading Device

Delivers the stem cells

Trial Locations (3)

43210

RECRUITING

The Ohio State University Wexner Medical Center, Columbus

85721

RECRUITING

University of Arizona, Tucson

90033

RECRUITING

Keck Medical Center of University of Southern California, Los Angeles

Sponsors

Lead Sponsor

Kenai Therapeutics
All Listed Sponsors
lead

Kenai Therapeutics

INDUSTRY

NCT07106021 - A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease | Biotech Hunter | Biotech Hunter